Cargando…

Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years

The objective of the present study was to evaluate the 2-year effectiveness of modified Shenzhuo formula in the treatment of overt proteinuria diabetic kidney disease (DKD). Patients diagnosed with type 2 DKD in the clinical research database of Prof Xiaolin Tong (>20,000 data points) with >1-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongdong, Guo, Jing, Zhao, Xuemin, He, Xinhui, He, Zhongchen, Zhao, Linhua, Tong, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371454/
https://www.ncbi.nlm.nih.gov/pubmed/28328817
http://dx.doi.org/10.1097/MD.0000000000006349
_version_ 1782518423272554496
author Chen, Hongdong
Guo, Jing
Zhao, Xuemin
He, Xinhui
He, Zhongchen
Zhao, Linhua
Tong, Xiaolin
author_facet Chen, Hongdong
Guo, Jing
Zhao, Xuemin
He, Xinhui
He, Zhongchen
Zhao, Linhua
Tong, Xiaolin
author_sort Chen, Hongdong
collection PubMed
description The objective of the present study was to evaluate the 2-year effectiveness of modified Shenzhuo formula in the treatment of overt proteinuria diabetic kidney disease (DKD). Patients diagnosed with type 2 DKD in the clinical research database of Prof Xiaolin Tong (>20,000 data points) with >1-year follow-up were screened for this study. Patients’ demographic data, chief complaint, present illness, past history, allergic history, personal history, family history, test results, tongue images, pulse information, and prescription information at 1, 1.5, and 2 years of follow-up were analyzed. EpiData3.1 was used to establish the electronic database of this research and SPSS v20.0 (SPSS Inc, Chicago, IL) was used for performing statistical analyses. The patients’ common main symptoms of overt proteinuria DKD were weak breath and fatigue, numbness of limbs, insomnia, blurred vision, nocturia, edema, low backache, constipation, itchy skin ulcer, and chills. The average 24-hour urinary protein of patients treated with modified Shenzhuo formula was statistically significantly lower than baseline values at 1, 1.5, and 2 years (0.66 g, 95% confidence interval [CI] [−0.95, −0.41]; 1.00 g, 95% CI [−1.67, 0.38]; 1.11 g, 95% CI [−1.79, −0.57]). There are no statistically significant differences between the glomerular filtration rate at the baseline and that after modified Shenzhuo formula intervention. Statistically significant reductions in serum triglyceride and glycosylated hemoglobin values and systolic blood pressure also were recorded. Other indexes, including serum creatinine, blood urea nitrogen, diastolic blood pressure, cholesterol, high-density lipoprotein, and low-density lipoproteins, did not differ between baseline and post-treatment time points. Modified Shenzhuo formula could reduce 24-hour urinary protein excretion in patients with DKD. The formula maybe had the potential advantages on glomerular filtration rate, creatinine reciprocal, blood lipid levels, etc.
format Online
Article
Text
id pubmed-5371454
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53714542017-04-03 Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years Chen, Hongdong Guo, Jing Zhao, Xuemin He, Xinhui He, Zhongchen Zhao, Linhua Tong, Xiaolin Medicine (Baltimore) 4300 The objective of the present study was to evaluate the 2-year effectiveness of modified Shenzhuo formula in the treatment of overt proteinuria diabetic kidney disease (DKD). Patients diagnosed with type 2 DKD in the clinical research database of Prof Xiaolin Tong (>20,000 data points) with >1-year follow-up were screened for this study. Patients’ demographic data, chief complaint, present illness, past history, allergic history, personal history, family history, test results, tongue images, pulse information, and prescription information at 1, 1.5, and 2 years of follow-up were analyzed. EpiData3.1 was used to establish the electronic database of this research and SPSS v20.0 (SPSS Inc, Chicago, IL) was used for performing statistical analyses. The patients’ common main symptoms of overt proteinuria DKD were weak breath and fatigue, numbness of limbs, insomnia, blurred vision, nocturia, edema, low backache, constipation, itchy skin ulcer, and chills. The average 24-hour urinary protein of patients treated with modified Shenzhuo formula was statistically significantly lower than baseline values at 1, 1.5, and 2 years (0.66 g, 95% confidence interval [CI] [−0.95, −0.41]; 1.00 g, 95% CI [−1.67, 0.38]; 1.11 g, 95% CI [−1.79, −0.57]). There are no statistically significant differences between the glomerular filtration rate at the baseline and that after modified Shenzhuo formula intervention. Statistically significant reductions in serum triglyceride and glycosylated hemoglobin values and systolic blood pressure also were recorded. Other indexes, including serum creatinine, blood urea nitrogen, diastolic blood pressure, cholesterol, high-density lipoprotein, and low-density lipoproteins, did not differ between baseline and post-treatment time points. Modified Shenzhuo formula could reduce 24-hour urinary protein excretion in patients with DKD. The formula maybe had the potential advantages on glomerular filtration rate, creatinine reciprocal, blood lipid levels, etc. Wolters Kluwer Health 2017-03-24 /pmc/articles/PMC5371454/ /pubmed/28328817 http://dx.doi.org/10.1097/MD.0000000000006349 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 4300
Chen, Hongdong
Guo, Jing
Zhao, Xuemin
He, Xinhui
He, Zhongchen
Zhao, Linhua
Tong, Xiaolin
Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years
title Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years
title_full Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years
title_fullStr Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years
title_full_unstemmed Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years
title_short Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years
title_sort retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified shenzhuo formula for 2 years
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371454/
https://www.ncbi.nlm.nih.gov/pubmed/28328817
http://dx.doi.org/10.1097/MD.0000000000006349
work_keys_str_mv AT chenhongdong retrospectiveanalysisoftheovertproteinuriadiabetickidneydiseaseinthetreatmentofmodifiedshenzhuoformulafor2years
AT guojing retrospectiveanalysisoftheovertproteinuriadiabetickidneydiseaseinthetreatmentofmodifiedshenzhuoformulafor2years
AT zhaoxuemin retrospectiveanalysisoftheovertproteinuriadiabetickidneydiseaseinthetreatmentofmodifiedshenzhuoformulafor2years
AT hexinhui retrospectiveanalysisoftheovertproteinuriadiabetickidneydiseaseinthetreatmentofmodifiedshenzhuoformulafor2years
AT hezhongchen retrospectiveanalysisoftheovertproteinuriadiabetickidneydiseaseinthetreatmentofmodifiedshenzhuoformulafor2years
AT zhaolinhua retrospectiveanalysisoftheovertproteinuriadiabetickidneydiseaseinthetreatmentofmodifiedshenzhuoformulafor2years
AT tongxiaolin retrospectiveanalysisoftheovertproteinuriadiabetickidneydiseaseinthetreatmentofmodifiedshenzhuoformulafor2years